CoChat

Interactions of IGF-1 with the Blood-Brain Barrier in vivo and in situ

Pan, Weihong, Kastin, Abba J. · 2000 · Neuroendocrinology

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

Insulin-like growth factor-1 (IGF-1) given peripherally has been found effective in clinical trials to slow down neuronal degeneration in some nervous system diseases. This raises the question of whether and how IGF-1 crosses the blood-brain barrier (BBB). In this report, we found that IGF-1 had a half-life of 4.5 min in blood, could remain intact for 20 min, and entered brain and spinal cord linearly. In the brain, IGF-1 had an influx rate of 0.4 µl/g·min after intravenous (iv) bolus injection as determined by multiple-time regression analysis. Intact radiolabeled IGF-1 was present in brain at 20 min after iv injection. Most of the injected IGF-1 entered the brain parenchyma instead of being entrapped in the cerebral vasculature. Addition of nonradiolabeled IGF-1 enhanced the influx of radiolabeled IGF-1 after iv injection, but inhibited the influx of radiolabeled IGF-1 by in-situ brain perfusion, suggesting that protein binding can explain the difference between the iv and perfusion experiments. In the spinal cord, the cervical region had the fastest uptake, followed by lumbar spinal cord. The thoracic spinal cord had the slowest uptake, comparable to that of brain. By contrast, des(1-3)IGF-1, an IGF-1 analogue with little protein binding but similar biological activity, had a shorter half-life in blood, slower influx rate into brain, and no alteration in pharmacokinetics after addition of nonradiolabeled peptide. We conclude that IGF-1 enters the CNS by a saturable transport system at the BBB, which functions in synchrony with IGF binding proteins in the periphery to regulate the availability of IGF-1 to the CNS.

Overview

Integrity signals

Registry

Crossref · 10.1159/000054584

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 24 references

Cited by

Items 201–206 of 206

Metadata

Authors
Pan, W., & Kastin, A. J.
Affiliations
Tulane University (US)
Venue
Neuroendocrinology
Publisher
S. Karger AG
Published
2000
Volume
72
Issue
3
Pages
171-178
ISSN
  • 0028-3835 (ISSN-L)
  • 1423-0194
OpenAlex
W2093730240
Cited by
185
References
24
Citations by year
2026: 8 · 2025: 4 · 2024: 29 · 2023: 13 · 2022: 7 · 2021: 4 · 2020: 10 · 2019: 3 · 2018: 4 · 2017: 4 · 2016: 8 · 2015: 2 · 2014: 6 · 2013: 11 · 2012: 9
FWCI
1.39
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Neuroendocrinology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK-54880)
Topics
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords
insulin-like growth factor I, blood-brain barrier, IGF binding proteins, protein binding, saturable transport, neuroprotection
MeSH terms
Animals, Biological Transport, Blood Chemical Analysis, Blood Circulation Time, Blood-Brain Barrier, Brain, Carrier Proteins, Cerebrovascular Circulation, Chromatography, High Pressure Liquid, Insulin-Like Growth Factor I, Iodine Radioisotopes, Male, Mice, Inbred ICR, Peptide Fragments, Radionuclide Imaging, Regression Analysis, Spinal Cord, Neurodegenerative Diseases, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.